Insightec's tremor treatment covered by Medicare

By staff writers

July 13, 2020 -- Insightec has secured coverage for Medicare beneficiaries in all U.S. states for its MR-guided focused ultrasound device, Exablate Neuro.

The device enables treatment of essential tremor and tremor-dominant Parkinson's disease with incisionless surgery. The U.S. Food and Drug Administration (FDA) cleared the device for use in the U.S. in 2016.

Medicare beneficiaries in 38 U.S. states previously had coverage for the treatment. Exablate Neuro is also available as a covered benefit on 22 independent Blue Cross Blue Shield plans, the company said.

Copyright © 2020

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking